Christine Kao / STAT Verily leans into Onduo as it looks to enter the lucrative world of running research The new, streamlined Verily will have one very recognizable component: its virtual care company Onduo, whose prodigious data collection from chronic disease patients will help power Verily's significant push into research on new drugs, devices, and treatment approaches.
Onduo was largely absent from a memo released last week announcing layoffs at the Alphabet spinout. But STAT has learned that Onduo is very much part of Verily’s plan, and that its leader, Vindell Washington, will remain at the company in a new role. Read More If you’d like to stop receiving these alerts, click on the "update email preferences" link below. | 
No comments